This formula approaches hair thinning through three complementary mechanisms.

‍
Finasteride helps reduce DHT activity at the follicle. DHT is a major contributor to progressive follicle miniaturization in androgenetic hair loss.

‍
Minoxidil supports follicle activity and helps extend the active growth phase of the hair cycle. Clinical studies support the combination of topical Finasteride and Minoxidil for androgenetic hair loss.

‍
Tretinoin affects the outer layers of the skin and can increase Minoxidil penetration, creating a more intensive topical approach for appropriate patients.

‍
Together, the formula is designed to help protect existing hair while supporting stronger, denser-looking growth over time.

With consistent treatment, the formula may support:

‍
• Reduced appearance of thinning
• Better hair retention
• Improved density
• Fuller-looking growth
• Support for thinning crown and hairline areas

‍
Hair-growth treatment takes time. Improvement generally develops gradually over several months, and continued use is usually necessary to maintain results.

‍
Temporary shedding or scalp irritation can occur when beginning treatment.

Before starting treatment, your medical prescriber will review your pattern of hair loss, medical history, current medications, scalp health, previous treatments, and hair-restoration goals to determine whether this combination is appropriate for you.

Let your provider know about any history of scalp sensitivity, significant skin conditions, heart or blood-pressure concerns, hormone-related conditions, fertility concerns, or reactions to previous hair-loss treatments. Mild dryness, redness, flaking, or irritation can occur with topical treatment, particularly because the formula contains tretinoin.

Use only on the scalp and exactly as prescribed. Your provider can adjust the application schedule if additional scalp sensitivity develops.

Prescription required.